Adiponectin Levels after Treatment With Liraglutide (Victoza®) in Patients With Type 2 Diabetes

被引：0
|
作者：
Daskalova, Ivona
Totomirova, Tzvetelina
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2591-PO
引用
收藏
页码：A659 / A659
页数：1
相关论文
共 50 条
  • [41] Effects of pravastatin on serum adiponectin levels in female patients with type 2 diabetes mellitus
    Kim, Ji-Hyun
    Lee, Ma-Rie
    Shin, Jung-Ah
    Lee, Sung-Soo
    Lee, Jung-Min
    You, Soon-Jib
    Yoon, Kun-Ho
    Chang, Sang-Ah
    ATHEROSCLEROSIS, 2013, 227 (02) : 355 - 359
  • [42] Blood adiponectin levels are not associated with risk of cardiovascular events in patients with type 2 diabetes
    Jeon, Ja Young
    Ha, Kyoung Hwa
    Han, Seung Jin
    Kim, Hae Jin
    Lee, Kwan-Woo
    Kim, Dae Jung
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (06): : 571 - 575
  • [43] Serum Adiponectin and Insulin Levels in Asymptomatic Offspring's of patients with Type 2 Diabetes
    Anwar, Muhammad Jawad
    Jamil, Rabiya
    Rashid, Nasir
    Rashid, Yahya
    Farooq, Muhammad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (04): : 1251 - 1252
  • [44] Low Adiponectin Levels and Increased Risk of Type 2 Diabetes in Patients With Myocardial Infarction
    Lindberg, Soren
    Jensen, Jan S.
    Pedersen, Sune H.
    Galatius, Soren
    Frystyk, Jan
    Flyvbjerg, Allan
    Bjerre, Mette
    Mogelvang, Rasmus
    DIABETES CARE, 2014, 37 (11) : 3003 - 3008
  • [45] Treatment Satisfaction With Albiglutide and Liraglutide in Patients With Type 2 Diabetes Uncontrolled With Oral Therapy
    Martin, Alan A.
    Johnson, Susan L.
    Ye, June
    Pratley, Richard E.
    DIABETES, 2013, 62 : A259 - A260
  • [46] Influence of liraglutide treatment in obstructive sleep apnoea in obese type 2 diabetes patients
    Abreu, C.
    Gomez-Peralta, F.
    Castro, J.
    Alcarria, E.
    Cruz-Bravo, M.
    Llorente, M.
    Albornos, C.
    Moreno, C.
    Cepeda, M.
    Almodovar, F.
    DIABETOLOGIA, 2014, 57 : S371 - S371
  • [47] Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment
    Rafiullah, Mohamed
    Benabdelkamel, Hicham
    Masood, Afshan
    Ekhzaimy, Aishah A.
    Musambil, Mohthash
    Joy, Salini Scaria
    Alfadda, Assim A.
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (02) : 1407 - 1421
  • [48] Quantitative and Qualitative Effect of Dulaglutide in Type 2 Diabetes Patients Under Treatment with Liraglutide
    Sotiropoulos, Alexios
    Koutsovasilis, Anastasios
    Antoniou, Anastasia
    Bousboulas, Stavros
    Peppas, Theodoros
    DIABETES, 2019, 68
  • [49] Long Term Follow Up of Patients With Type 1 Diabetes on Liraglutide and the Effect of Liraglutide as Additional Treatment in Obese Patients With Type 1 Diabetes
    Kuhadiya, Nitesh D.
    Malik, Ritu
    Bellini, Natalie
    Lyons-Patterson, Jane
    Traina, Andrea
    Makdissi, Antoine
    Dandona, Paresh
    DIABETES, 2012, 61 : A284 - A284
  • [50] Efficacy and safety of a combination of insulin degludec and liraglutide (IDegLira) in patients with Type 2 diabetes after 1 year of treatment
    Gough, S. C. L.
    Woo, V. C.
    Rodbard, H. W.
    Linjawi, S.
    Poulsen, P.
    Korsholm, L.
    Bode, B. W.
    DIABETIC MEDICINE, 2015, 32 : 76 - 76
12345